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ABSTRACT
Rationale: Dyspnoea is a debilitating and distressing
symptom that is reflected in different verbal descriptors.
Evidence suggests that dyspnoea, like pain perception,
consists of sensory quality and affective components. The
objective of this study was to develop an instrument that
measures overall dyspnoea severity using descriptors that
reflect its different aspects.
Methods: 81 dyspnoea descriptors were administered to
123 patients with chronic obstructive pulmonary disease
(COPD), 129 with interstitial lung disease and 106 with
chronic heart failure. These were reduced to 34 items
using hierarchical methods. Rasch analysis informed
decisions regarding further item removal and fit to the
unidimensional model. Principal component analysis (PCA)
explored the underlying structure of the final item set.
Validity and reliability of the new instrument were further
assessed in a separate group of 53 patients with COPD.
Results: After removal of items with hierarchical
methods (n = 47) and items that failed to fit the Rasch
model (n = 22), 12 were retained. The ‘‘Dyspnoea-12’’
had good internal reliability (Cronbach’s alpha = 0.9) and
fit to the Rasch model (x2 p = 0.08). Items patterned into
two groups called ‘‘physical’’(n = 7) and ‘‘affecti-
ve’’(n = 5). In the separate validation study, Dyspnoea-12
correlated with the Hospital Anxiety and Depression Scale
(anxiety r = 0.51; depression r = 0.44, p,0.001,
respectively), 6-minute walk distance (r =20.38,
p,0.01) and MRC (Medical Research Council) grade
(r = 0.48, p,0.01), and had good stability over time
(intraclass correlation coefficient = 0.9, p,0.001).
Conclusion: Dyspnoea-12 fulfills modern psychometric
requirements for measurement. It provides a global score
of breathlessness severity that incorporates both ‘‘physi-
cal’’ and ‘‘affective’’ aspects, and can measure dyspnoea
in a variety of diseases.
Dyspnoea is a perceptual experience that is
complex and highly subjective. It is a common
and distressing symptom in cardiorespiratory dis-
ease. Progress has been made in identifying various
aspects of dyspnoea that arise from multiple
factors including environmental, psychological
and physiological.1 Other evidence indicates that
dyspnoea, like pain perception, consists of ‘‘sensory
quality’’ and ‘‘affective’’ components,2 3 yet no
currently available dyspnoea instrument encom-
passes these.
Dyspnoea has been measured in two ways: (1)
directly, using modified Borg or visual analogue
scales, in persons experiencing dyspnoea at rest or
in response to various stimuli4–6; single item scales
may not be adequate enough to capture dyspnoea
complexity; and (2) indirectly, by asking the
respondent to report the level of physical activity
they are not able to accomplish because of
dyspnoea,7 8 or within scales assessing the impact
of disease on quality of life.9 10 Whilst indirect
methods provide useful information, they do not
quantify dyspnoea; they measure its effects on
activity. This also means that they cannot measure
different aspects of dyspnoea.
Patients with cardiorespiratory disease use a
variety of terms to describe the experience of being
breathless, and it has been proposed that dyspnoea
descriptors may provide a direct route for its
quantification.11 12 Studies have explored the seman-
tics of dyspnoea, principally from a diagnostic
perspective, or to understand mechanisms.13–16
That work utilised descriptor lists that focused
primarily on sensory quality, but evidence suggests
that sensory quality descriptors are not sufficiently
robust to aid differential diagnosis, since they reflect
a variety of sensations which are shared by a range of
conditions.13 16 17 Whilst they may have limited
diagnostic utility, verbal descriptors have been found
to be related to the severity level of dyspnoea in
patients with cardiorespiratory disease, providing a
mechanism for its assessment.18 19
The affective aspect of dyspnoea evokes distress
and motivates behaviour, often overlooked in
clinical and laboratory settings. This may be, in
part, because no measure of this dimension
currently exists. Evidence for a range of descriptors
representative of affect has evolved from studies in
which patients were asked to describe the experi-
ence of being breathlessness in their own words.20–23
Affect-laden descriptors were relatively consistent
between studies, yet it is not known which of these
may possess reliable measurement properties.
Taken together, this work has created a body of
language that reflects multiple aspects of dys-
pnoea. A core list of dyspnoea descriptors that
patients consider most relevant has not previously
been defined. Our objective was to develop a
concise and valid questionnaire of overall dyspnoea
severity using descriptors that were relevant across
different cardiorespiratory diseases. Our underlying
hypothesis was that the words patients use can be
applied to form a reliable scale that reflects
dyspnoea severity. This paper presents two studies:
the development of a new questionnaire for the
quantification of dyspnoea and its initial valida-
tion.
MATERIALS AND METHODS
Development of the initial item pool
A pool of 81 items was generated from published
literature reporting the language to describe
breathlessness. Papers were identified by a sys-
tematic search of Medline, CINAHL and PsychInfo
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(up to October 2005) using the terms: dyspnoea/dyspnea or
breathless/breathlessness, and language/descriptor/question-
naire/qualitative. One patient with chronic obstructive pul-
monary disease (COPD) and one with interstitial lung disease
(ILD) assisted the removal of duplicate items and advised on the
structure of each phrase and severity response scale used. The 81
items, each with response options of ‘‘none’’, ‘‘mild’’, ‘‘moder-
ate’’ or ‘‘severe’’, were arranged as a questionnaire list that asked
patients to respond to each item that ‘‘best matched’’ their
current experience of being breathless. Two studies were
performed; both were approved by the local ethics research
committees and written consent was obtained from all
participants.
Study one: item reduction and preliminary testing
Study participants and measures
Breathless patients (n = 358) with a primary diagnosis of
COPD, ILD or chronic heart failure (CHF), and able to read
English, were recruited through outpatient clinics from three
hospitals in England. Each participant completed one of three
randomly allocated 81-item descriptor lists, the Medical
Research Council (MRC) dyspnoea scale,8 and two modified
Borg scales6 that assessed ‘‘current level of breathlessness’’ and
‘‘current level of distress caused by breathlessness’’.
Study phases
Phase 1
Item reduction using hierarchical methods24: to remove the least
discriminative descriptors, items were excluded if >50% of
patients gave a response of ‘‘none’’. Items influenced by age at
p,0.05 (Pearson correlation r) were removed.
Phase 2
Item reduction using Rasch analysis: items that survived hierarch-
ical reduction were analysed with Rasch (RUMM2020 soft-
ware).25 Rasch models provide a template for testing how well
each item contributes to the concept being measured (breath-
lessness severity).26 This is an iterative process whereby the
poorest fitting item is removed and the effect on the fit of the
remaining items is then retested. This process is continued until
each item demonstrates a good fit to the model and the stability
of the overall item set also to meet the requirement for it to be a
reliable unidimensional measure. In a Rasch model, severity
associated with any given item is measured in ‘‘logits’’—which
is the log odds of a patient of a given level of breathlessness
severity, as assessed by their response to all the items combined,
having a 50% chance of responding positively to that item.27
Individual item fit was assessed using a x2 statistic to compare
the difference between the observed responses and those
expected by the model.28 Analysis of variance (ANOVA) was
used to test each item for the influence of gender or diagnosis on
the patients’ response to that item, an effect known as
differential item functioning (DIF). Further details regarding
individual item tests of fit and DIF are provided in the online
supplement (see supplementary figs 1–4).
The presence of any item–trait interaction was tested using a x2
test to assess whether all items perform consistently, regardless of
overall breathlessness severity (determined by p.0.05). Internal
reliability was assessed using Cronbach’s reliability (a).29
Phase 3
Exploratory principal component analysis (PCA): PCA using
varimax rotation was used to assess the underlying structure
of the final item set. The number of components extracted was
based on eigenvalues, and allocation of an item to a component
was determined by a factor loading which by convention is set
at .0.5.29
Phase 4
Preliminary validity testing of the final 12-item set: the final item set
consists of 12 items. The score is calculated using simple
addition of the responses for each item. It ranges from 0 to 36,
where 0 represents no breathlessness and 36 represents maximal
severity.
Pearson (r) correlations examined relationships between the
12-item set total score, MRC dyspnoea grade, Borg-intensity
and Borg-distress scales. The effect of diagnosis on differences in
the 12-item set score across MRC dyspnoea grades was tested
using ANOVA. The average Dyspnoea-12 score and Borg-
intensity and Borg-distress scores were computed for each
category of MRC dyspnoea grade for the entire group (n = 358).
Study two: Dyspnoea-12 validation
The final version is called Dyspnoea-12 (Appendix 1). The
Dyspnoea-12 asks patients to respond to each item in relation to
their breathlessness ‘‘these days’’ and is designed to capture the
patient’s general perception about their current state, rather
than a record specific to the day of testing. This time reference
frame was used because it has been found to be reliable in other
instruments such as the St George’s Respiratory Questionnaire.9
Study participants and measures
In the separate study, we tested Dyspnoea-12 reliability and
validity with a further group of 53 patients with COPD. During
a routine clinic visit participants completed the Dyspnoea-12,
MRC dyspnoea scale,8 Hospital Anxiety and Depression Scale
(HADS),30 lung function tests and 6-minute walk distance
(6MWD). All patients repeated the Dyspnoea-12 after a median
of 16 days (range 10–20). Dyspnoea-12 internal consistency was
assessed using Cronbach a, and test–retest reliability was tested
using the intraclass correlation coefficient (ICCC). Correlations
using Pearson (r) were examined between Dyspnoea-12, MRC
grade, HADS, forced expiratory volume in 1 s (FEV1) and
6MWD.
Face validity was explored using qualitative methods (6
patients with COPD, 2 with ILD and 4 with CHF). These
patients also rated the Dyspnoea-12 for ease of completion
(0 = not easy to 10 = extremely easy); helpful in expressing their
experience (0 = not helpful to 10 = extremely helpful); and ease
of completion (0 = not easy to 10 = extremely easy).
RESULTS
Study one
A total of 358 patients completed the questionnaires; most
(n = 275, 77%) completed these during a clinic visit, the
remainder for return within 2 weeks. The majority were
Caucasian (n = 337, 94%). Their baseline characteristics are
provided in table 1.
Phase 1
Forty-seven items were initially removed because >50% of
participants rated them as ‘‘none’’; one item (‘‘breathing more’’)
was associated with age (p = 0.02) (see supplementary table 1
online).
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Phase 2
Rasch analysis was applied to the remaining 34 items. Twenty-
two items were removed due to lack of fit to the Rasch model
(see supplementary table 1 online). Twelve items survived the
item reduction process, and make up the final item set. The 12-
item set had very good internal reliability (a= 0.9). The item–
trait x2 probability was p = 0.08, supporting the conclusion that
the items formed a unidimensional measure of overall breath-
lessness severity.
The DIF tests for two items (‘‘distressing’’ and ‘‘difficulty
catching breath’’) suggested that they behaved differently
between diseases (p,0.002); however, the effect on the overall
score for dyspnoea severity was negligible. Overall severity of
the patients with these items included was 20.627 (1.4) mean
(SD) logits and with the items removed it was 20.625 (1.4)
logits, so they were retained.
Phase 3
Exploratory PCA of the 12 items identified one component with
an eigenvalue .1, explaining 58% of the variance (see
supplementary table 2 online), and supports the conclusion
from the Rasch item–trait test that the items form a
unidimensional model. The second component had an eigenva-
lue .0.9 and explained 8% of the variance, so a two-component
structure was forced to explore the patterning of items further.
The first component called ‘‘physical’’ contained seven items
and the second, called ‘‘affect’’, contained five items (table 2).
One item ‘‘irritating’’ loaded .0.5 on both components. The
apparent paradox of a unidimensional structure with perhaps
two components is explained by the severity associated with
the groups of items. The ‘‘physical’’ items were associated with
a lower overall level of dyspnoea severity (mean =20.17 logits)
whereas the ‘‘affective’’ items were associated with more severe
breathlessness (mean = 0.24 logits) (fig 1).
Phase 4
For the entire sample (n = 358) the 12-item set total score
correlated significantly with Borg-intensity (r = 0.47, p,0.001),
Borg-distress (r = 0.59, p,0.001) and MRC grade (r = 0.39,
p,0.001). The relationship between the 12 items and MRC
grade was not dependent on diagnosis (F = 1.3, p.0.05 for the
interaction). The average 12 items total score, Borg-distress
ratings and Borg-intensity ratings increased progressively with
similar gradients of between 8% and 10% of full scale per
increment in MRC grade (fig. 2).
Study two
Fifty-three patients with COPD (32 male) participated in the
separate validation study. The groups mean age was 69 (16);
FEV1 (litres/min) 1.43 (0.7); FEV1/FVC % predicted 55 (16); and
6MWD (metres) 181 (175). The mean Dyspnoea-12 score for the
sample was 18 (8); MRC grade 2.6 (1.3); HADS anxiety 8.7
(1.3); and HADS depression 7.7 (4). Dyspnoea-12 demonstrated
good internal reliability (a= 0.9) and good test–retest reliability
(ICCC = 0.90, p,0.001). Mean Dyspnoea-12 score was strongly
associated with HADS scores (anxiety r = 0.51 and depression
r = 0.44, p,0.001). Dyspnoea-12 correlated significantly with
FEV1 (r =20.30, p = 0.03), 6MWD (r =20.38, p,0.01) and
MRC grade (r = 0.48, p,0.001).
Interview participants rated the Dyspnoea-12 as easy to
complete (median = 9; range = 5–10), easy to understand
(median = 9.5; range = 5–10) and helpful (median = 9;
range = 5–10). One man with COPD commented that the
questionnaire was ‘‘superb’’ and enabled him to say ‘‘right this
is how I feel’’.
DISCUSSION
We have developed and conducted initial validity testing of the
Dyspnoea-12. It was derived from the largest pool of breath-
lessness descriptors that has been assembled. This is a unique
instrument since it quantifies breathlessness using descriptions
by patients of its qualities and its affective sequelae. We have
demonstrated the concurrent validity of Dyspnoea-12 with
other relevant measures. Uniquely, this instrument was
developed in three disease populations. Its relationship to
MRC grade was independent of diagnosis, enabling it to make
direct comparisons of dyspnoea severity between patients with
different diseases. Patients found the Dyspnoea-12 was easy to
complete and understand, and helpful in expressing their
experience of being breathless.
Unlike other self-report breathlessness instruments,
Dyspnoea-12 does not depend on a reference level of activity
or any specific type of activity. The reference frame ‘‘these
days’’ is designed not to be situation specific but to be
temporally specific—in terms of how patients currently
experience breathlessness in their daily lives, as opposed to
specifically on the day of the test or in response to a specific
activity. When using this reference, patients’ responses may be
determined in part by the nature and intensity of their day-to-
day activities, but this possibility requires testing.
In developing this instrument, we used advanced methodol-
ogy to ensure reliable measurement properties, and it represents
the first application of Rasch methodology to the measurement
of breathlessness. Our use of Rasch modelling facilitated the
development of a questionnaire that provides measurement of
dyspnoea using a parsimonious collection of items that form a
unidimensional measure. Rasch analysis determined the mini-
mum level of items required to represent the underlying
construct being measured (ie, breathlessness severity). There
are no rules that determine the number of items in a
questionnaire; the optimum number is determined by achieving
a balance between economy, precision and reliability. This is
different for every instrument. Rasch methodology indicates
when internal reliability begins to deteriorate with further item
removal, and we found that 12 items provided the best
compromise.
The 12 items contribute reliably to the measurement of
overall dyspnoea severity, even though some address the
affective consequences of breathlessness (eg, ‘‘makes me feel
miserable’’) and some measure physical aspects (eg, ‘‘more
Table 1 Study one sample demographics (mean (SD))
COPD ILD CHF
n = 123 n = 129 n = 106
Male gender 62 (51%) 47 (36%) 72 (68%)
Age, years 69 (8) 50 (12) 68 (11)
FEV1 % predicted 48 (16) 69 (22) –
FVC % predicted 72 (19) 69 (19) –
FEV1:FVC % predicted 55 (12) 83 (8) –
Left ventricular ejection
fraction
– – 35 (15)
MRC grade (1–5) 3.4 (1.1) 3.0 (1.1) 2.6 (1.1)
Borg-intensity 3.1 (1.9) 3.6 (2.1) 2.2 (1.9)
Borg-distress 4.5 (2.4) 3.7 (2.2) 3.4 (2.4)
CHF, chronic heart failure; COPD, chronic obstructive lung disease; FEV1, forced
expiratory volume in 1 s; FVC, forced vital capacity; ILD, interstitial heart disease;
MRC, Medical Research Council.
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work’’). ‘‘Physical’’ items tended to be associated with milder
severity, whereas the ‘‘affective’’ items were associated with
more severe breathlessness. Differences in breathlessness sever-
ity associated with physical and affective items explain the
patterning of items observed with PCA. These findings
demonstrate the benefit of combining both physical and
affective aspects in a dyspnoea scale if it is to cover a broad
range of overall breathlessness severities.
We are not the first to hypothesise a multiple component
dyspnoea model, since it has been suggested that a multi-
dimensional instrument used to measure pain could be adapted
to measure dyspnoea.31 Our findings are compatible with this
hypothesis, since we found that a range of different descriptors
from the physical to affective components of dyspnoea could be
combined to form a single overall unidimensional scale. Our
approach created a pragmatic, usable scale using rigorous
methodology. Our primary objective was to develop an overall
measure of breathlessness severity. To do this, we required all
items to fit a unidimensional model. Thus, we only included
‘‘physical’’ and ‘‘affective’’ items that reflected overall severity
in a similar way. This process may have excluded ‘‘physical’’ or
‘‘affective’’ items that may have behaved differently, with
different measurement properties. The ‘‘physical’’ and ‘‘affec-
tive’’ components may be referred to as ‘‘components’’ in
questionnaire parlance, but should be used only for exploratory
analyses.
Patient-reported outcomes such as the Dyspnoea-12 should
be derived from the words used by patients to describe disease
effects and their clinical state. We are indebted to workers who
collected those descriptors in previous studies. We developed
our initial 81-item pool after a systematic review of existing
literature and were struck by the similarity of items identified
by different research groups. Moreover, during interview
sessions patients were invited to volunteer any other terms;
no new terms were provided. We are confident that the
Dyspnoea-12 items are relevant, appropriate and truly capture
patients’ perceptions.
The terms ‘‘work’’ and ‘‘effort’’ are often used interchange-
ably, in part because they tended to form into one cluster.13–15
We found that the term ‘‘more work’’ had more reliable patient
responses than ‘‘hard work’’ and ‘‘more effort’’. Likewise, the
term ‘‘panic’’ is often associated with the perception of
breathlessness,21 22 32 yet in this large patient cohort responses
to this item were erratic, so it was removed. Two of the final 12
items did demonstrate DIF associated with diagnosis. We chose
to retain these because the effect of this bias on the overall score
was negligible. Furthermore, the descriptors ‘‘distressing’’ and
‘‘difficulty catching breath’’ have not previously been noted as
being specific to any particular disease, so this may have been a
chance finding.
Table 2 Principal components analysis with varimax rotation of the 12-
item set
Item
Component 1
‘‘Physical’’
Component 2
‘‘Affect’’
My breath does not go in all the way 0.811
My breathing requires more work 0.715 0.333
I feel short of breath 0.713 0.313
I have difficulty catching my breath 0.696 0.320
I cannot get enough air 0.688 0.398
My breathing is uncomfortable 0.653 0.456
My breathing is exhausting 0.578 0.479
My breathing makes me feel
depressed
0.834
My breathing makes me feel miserable 0.821
My breathing is distressing 0.357 0.725
My breathing makes me agitated 0.488 0.658
My breathing is irritating 0.508 0.530
Items were allocated to a component if they loaded .0.5, as per figures highlighted in
bold.
Figure 1 Illustration of logit (ie,
severity) value for each item. *Indicates
item loading onto the ‘‘physical’’
component identified with principal
component analysis (PCA). {Indicates
item loading onto the ‘‘affective’’
component identified with PCA. The value
attached to each descriptor is the logit
(ie, severity) associated with that
descriptor (negative values indicate
milder, positive values indicate more
severe). By convention, in Rasch analysis
the severity scale is centred on zero
logits. Note: these logit values are not
used to score the instrument; they are
shown here to illustrate the different
relative severity of the items.
Figure 2 Mean (+95%CI) of total Dyspnoea-12 scores (D12-TOTAL),
Borg-intensity (Borg-INT) and Borg-distress scores (Borg-DIS) at each
Medical Research Council (MRC) dyspnoea grade for all three conditions
combined (n = 358). Ratings for all three measures increased
progressively with similar gradients of between 8% and 10% of full scale
per increment in MRC grade.
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Whilst we have demonstrated concurrent validity and
repeatability of the Dyspnoea-12 in a different sample from
that used in its development, a larger prospective study is
needed to confirm these findings. The Dyspnoea-12 correlated
well with Borg-distress and HADS scores. The direction of
causality in these relationships is yet to be determined, but one
hypothesis is that a person’s level of psychological distress has
an impact on their perceived breathlessness severity,32 although
distress due to dyspnoea could also increase anxiety. The
Dyspnoea-12 provides a method of breathlessness measurement
that may allow this relationship to be explored further. It
should have utility in clinical trials of new treatments targeted
at the emotional impact of breathlessness, since it incorporates
items related to the affective aspect of breathlessness severity.
Dyspnoea-12 is currently validated for the English-speaking
population; translations into other languages will require
careful translation, back-translation, and cultural and linguistic
validation to ensure that it performs in the same way.
In summary, the Dyspnoea-12 forms a unidimensional
measure that reflects both the physical and affective aspects
of dyspnoea. It addresses the need for a comprehensive
dyspnoea instrument and is based on the language used by
patients to describe the experience. It can measure breath-
lessness across several disease groups, is simple and quick to use
and should find utility in routine clinical monitoring, clinical
research and trials of interventions designed to ameliorate the
impact of breathlessness.
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APPENDIX: DYSPNOEA-12 QUESTIONNAIRE
This questionnaire is designed to help us learn more about how your breathing is troubling you.
Please read each item and then tick in the box that best matches your breathing these days. If you do not experience an item tick the ‘‘none’’ box. Please respond to all items.
We do not recommend use of the instrument with data from more than three items missing. The method for scoring the Dyspnoea-12 with up to three missing items is detailed in
the table below.
Item None Mild Moderate Severe
1. My breath does not go in all the way
2. My breathing requires more work
3. I feel short of breath
4. I have difficulty catching my breath
5. I cannot get enough air
6. My breathing is uncomfortable
7. My breathing is exhausting
8. My breathing makes me feel depressed
9. My breathing makes me feel miserable
10. My breathing is distressing
11. My breathing makes me agitated
12. My breathing is irritating
Number of items missing Calculation to account for missing items Dyspnoea-12 score calculation
1 36 4 33 = 1.09 1.16 total Dyspnoea-12 score
2 36 4 30 = 1.2 1.26 total Dyspnoea-12 score
3 36 4 27 = 1.3 1.36 total Dyspnoea-12 score
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